Trial Profile
Clinical trial phase I-II of Topotect (dexrazoxane) and high doses of etoposide in the treatment of adult patients with solid primary or secondary brain tumors
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 17 Apr 2015
Price :
$35
*
At a glance
- Drugs Dexrazoxane (Primary) ; Etoposide
- Indications Brain metastases
- Focus Adverse reactions; Therapeutic Use
- Sponsors TopoTarget
- 17 Apr 2015 New trial record